Mills et al. in their study classified patients with PNPO mutation into three groups, group 1 being neonatal onset seizures responding to PLP, group 2 being infantile spasms responsive to PLP, and group 3 being seizures starting under 3 months of age responding to pyridoxine (Mills et al., 2014). Here, PNPO is linked to infantile spasms.